Germline variation and risk of immune-related adverse events (irAEs): A real-world BioVU study

被引：0
|
作者：
Balko, Justin M.
Yao, Lydia
Zhang, Siwei
Fahey, Catherine
Haugh, Alexandra
Davis, Andrea
Mukherjee, Eric
Hammer, Christian
Phillips, Elizabeth J.
Bejan, Cosmin A.
Xu, Yaomin
Johnson, Douglas Buckner
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] UCSF Hem, Onc Fellowship, San Francisco, CA USA
[3] Univ Colorado, Denver, CO USA
[4] Genentech Inc, South San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10582
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Ophthalmic Immune-Related Adverse Events and Association with Survival: Results From a Real-World Database
    Quiruz, Lee
    Yavari, Negin
    Kikani, Bijal
    Gupta, Ankur Sudhir
    Wai, Karen Michelle
    Kossler, Andrea Lora
    Ludwig, Chase
    Koo, Eubee Baughn
    Rahimy, Ehsan
    Mruthyunjaya, Prithvi
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 268 : 348 - 359
  • [32] Germline determinants of immune related adverse events (irAEs) in melanoma immunotherapy response
    Kirchhoff, T.
    Ferguson, R.
    Simpson, D.
    Kazlow, E.
    Martinez, C.
    Vogelsang, M.
    Wilson, M.
    Pavlick, A. C.
    Weber, J. S.
    Osman, I.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Immune-related adverse events: Spectrum and clinical features in the real world
    Vieira, I. M.
    Pinelas, S.
    Gaspar, C.
    Dinis, J.
    Oliveira, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1434 - S1434
  • [34] Pharmacist's role in immune-related adverse events management: real-world incidence and risk evaluation from immunotherapy
    Meanwatthana, J.
    Chantarasap, P.
    Chuatrisorn, I
    Wiriya, T.
    Jitawatanarat, P.
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2022, 30 (04) : 377 - 382
  • [35] IMMUNE-RELATED ADVERSE EVENTS FROM IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A REAL-WORLD EXPERIENCE
    Gampa, Anuhya
    Peeraphatdit, Thoetchai
    Charlton, Michael R.
    Pillai, Anjana A.
    HEPATOLOGY, 2020, 72 : 694A - 695A
  • [36] Long-lasting, irreversible and late-onset immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs): A real-world data analysis.
    Ghisoni, Eleonora
    Wicky, Alexandre M.
    Latifyan, Sofiya
    Alfonso, Nuria Neisy Mederos
    Oezdemir, Berna C.
    Cuendet, Michel A.
    Imbimbo, Martina
    Marandino, Laura
    Delyon, Julie
    Gerard, Camille Lea
    Tavazzi, Erica
    Gatta, Roberto
    Valabrega, Giorgio
    Aglietta, Massimo
    Obeid, Michel
    Coukos, George
    Peters, Solange
    Di Maio, Massimo
    Bouchaab, Hasna
    Michielin, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Comment on Ophthalmic Immune-Related Adverse Events and Association With Survival: Results From a Real-World Database
    Lum, Flora
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 270 : 277 - 277
  • [38] The Impact of Body Mass Index on Immune-Related Adverse Events and Outcomes in Patients with Lung Cancer: A Real-World Study
    Hu, X.
    Gurinovich, A.
    Pan, S.
    Salei, Y. V.
    Lin, J. H.
    Rodday, A. M.
    Parsons, S. K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S611 - S612
  • [39] Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors
    Hu, Xiao
    Rodday, Angie Mae
    Gurinovich, Anastasia
    Pan, Stacey
    Salei, Yana V.
    Lin, Jeffrey H.
    Byrne, Margaret M.
    Cao, Yu
    Pai, Lori
    Parsons, Susan K.
    IMMUNOTHERAPY, 2025,
  • [40] Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors
    Teng, Yi-Shan
    Yu, Sebastian
    CURRENT ONCOLOGY, 2023, 30 (07) : 6805 - 6819
12345